TRIJARDY XR

Empagliflozin, Linagliptin, Metformin hydrochloride · Boehringer Ingelheim Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for TRIJARDY XR, covering 2020-01-27 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: TRIJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)